Unknown

Dataset Information

0

Machine learning-based optimization of pre-symptomatic COVID-19 detection through smartwatch.


ABSTRACT: Patients with weak or no symptoms accelerate the spread of COVID-19 through various mutations and require more aggressive and active means of validating the COVID-19 infection. More than 30% of patients are reported as asymptomatic infection after the delta mutation spread in Korea. It means that there is a need for a means to more actively and accurately validate the infection of the epidemic via pre-symptomatic detection, besides confirming the infection via the symptoms. Mishara et al. (Nat Biomed Eng 4, 1208-1220, 2020) reported that physiological data collected from smartwatches could be an indicator to suspect COVID-19 infection. It shows that it is possible to identify an abnormal state suspected of COVID-19 by applying an anomaly detection method for the smartwatch's physiological data and identifying the subject's abnormal state to be observed. This paper proposes to apply the One Class-Support Vector Machine (OC-SVM) for pre-symptomatic COVID-19 detection. We show that OC-SVM can provide better performance than the Mahalanobis distance-based method used by Mishara et al. (Nat Biomed Eng 4, 1208-1220, 2020) in three aspects: earlier (23.5-40% earlier) and more detection (13.2-19.1% relative better) and fewer false positives. As a result, we could conclude that OC-SVM using Resting Heart Rate (RHR) with 350 and 300 moving average size is the most recommended technique for COVID-19 pre-symptomatic detection based on physiological data from the smartwatch.

SUBMITTER: Cho HR 

PROVIDER: S-EPMC9097889 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Machine learning-based optimization of pre-symptomatic COVID-19 detection through smartwatch.

Cho Hyeong Rae HR   Kim Jin Hyun JH   Yoon Hye Rin HR   Han Yong Seop YS   Kang Tae Seen TS   Choi Hyunju H   Lee Seunghwan S  

Scientific reports 20220512 1


Patients with weak or no symptoms accelerate the spread of COVID-19 through various mutations and require more aggressive and active means of validating the COVID-19 infection. More than 30% of patients are reported as asymptomatic infection after the delta mutation spread in Korea. It means that there is a need for a means to more actively and accurately validate the infection of the epidemic via pre-symptomatic detection, besides confirming the infection via the symptoms. Mishara et al. (Nat B  ...[more]

Similar Datasets

| S-EPMC9020268 | biostudies-literature
| S-EPMC8186799 | biostudies-literature
| S-EPMC10032660 | biostudies-literature
| S-EPMC10764024 | biostudies-literature
| S-EPMC10884486 | biostudies-literature
| S-EPMC10831249 | biostudies-literature
| S-EPMC7725992 | biostudies-literature
| S-EPMC9477266 | biostudies-literature
| S-EPMC8690000 | biostudies-literature
| S-EPMC10770131 | biostudies-literature